THE BOOK PROVIDES SCIENTIFIC EXPERTS WITH INFORMATION ON WHICH TO BASE COURT TESTIMONY, ATTORNEYS WITH FACTS FOR PROSECUTING OR DEFENDING DRUG CASES, AND PHYSICIANS WITH INFORMATION ON DRUGS AND DRUG LAWS RELEVANT TO MAINTAINING PROPER RECORDS AND PRESCRIPTION PRACTICES. THE MAIN SECTION IS AN ALPHABETICAL LISTING OF ALL SUBSTANCES CONTROLLED BY FEDERAL LAW, PLUS SELECTED DANGEROUS DRUGS (PRESCRIPTION AND NONPRESCRIPTION). THE SUBSTANCES ARE LISTED BY GENERIC NAME, WITH EACH ENTRY INCLUDING THE DRUG'S STATUS UNDER THE FEDERAL CONTROLLED SUBSTANCES ACT, ITS SYNONYMS, PHARMACEUTICAL PREPARATIONS CONTAINING THE DRUG, AND THE DRUG'S BIOCHEMISTRY, PHARMACOGNOSY, AND TOXICOLOGY-PHARMACOLOGY. DISCUSSIONS OF THE CONCEPT OF DRUGS, SPECIFICATIONS THAT PHARMACEUTICAL COMPANIES MUST MEET TO MARKET A NEW PRODUCT, THE PROVISIONS OF THE FEDERAL CONTROLLED SUBSTANCES ACT (INCLUDING REQUIREMENTS FOR REGISTRATION OF CONTROLLED SUBSTANCES), AND RULES AND REGULATIONS GOVERNING THE HANDLING OF DRUG EVIDENCE BY FORENSIC LABORATORIES ARE PROVIDED. ALSO INCLUDED ARE CHAPTERS ON PHARMACEUTICAL DOSAGE FORMS (AEROSOLS, CAPSULES, TABLETS, ETC.); EXCLUDED (NONPRESCRIPTION) AND EXPECTED (FROM THE FEDERAL CONTROLLED SUBSTANCES ACT) DRUGS; ISOMERS AND DERIVATIVES OF CONTROLLED DRUGS; AND TECHNIQUES AND INSTRUMENTS FOR ANALYZING DRUGS. AN INDEX, BIBLIOGRAPHY, AND A LIST OF REFERENCES ARE PROVIDED. (LKM)